Rachel Frank is currently the Senior Director and Head of Investor Relations & Corporate Communications at Bicara Therapeutics, a position they have held since 2024. Previously, Rachel worked at Kiniksa Pharmaceuticals from 2019 to 2021, where they served as Senior Manager and later as Senior Director of Investor Relations & Corporate Communications. Prior to that, Rachel contributed to Stern Investor Relations in various roles, including Senior Analyst and Director, throughout 2018. Rachel is pursuing a degree in Political Science at New York University.
Location
United States